FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313281041> ?p ?o ?g. }

• W4313281041 abstract "Abstract Glioma is the most common type of primary malignant tumor in the central nervous system with limited treatment satisfaction. Finding new therapeutic targets has remained a major challenge. Ferroptosis is a novel and distinct type of programmed cell death, playing a regulatory role in the progression of tumors. However, the role of ferroptosis or ferroptosis-related genes (FRGs) in glioma progression has not been extensively studied. In our study, a novel ferroptosis-related prognostic model, including 7 genes, was established, in which patients classified into the high-risk group had more immuno-suppressive status and worse prognosis. Among these 7 genes, we screened solute carrier family 1 member 5 (SLC1A5), an FRG, as a possible new target for glioma treatment. Our results showed that the expression of SLC1A5 was significantly upregulated in glioblastoma tissues compared with the low-grade gliomas. In addition, SLC1A5 knockdown could significantly inhibit glioma cell proliferation and invasion, and reduce the sensitivity of ferroptosis via the GPX4-dependent pathway. Furthermore, SLC1A5 was found to be related to immune response and SLC1A5 knockdown decreased the infiltration and M2 polarization of tumor-associated macrophages. Pharmacological inhibition of SLC1A5 by V9302 was confirmed to promote the efficacy of anti-PD-1 therapy. Overall, we developed a novel prognostic model for glioma based on the seven-FRGs signature, which could apply to glioma prognostic and immune status prediction. Besides, SLC1A5 in the model could regulate the proliferation, invasion, ferroptosis and immune state in glioma, and be applied as a prognostic biomarker and potential therapeutic target for glioma." @default.
• W4313281041 created "2023-01-06" @default.
• W4313281041 creator A5012660792 @default.
• W4313281041 creator A5013285310 @default.
• W4313281041 creator A5018244700 @default.
• W4313281041 creator A5024152585 @default.
• W4313281041 creator A5024671320 @default.
• W4313281041 creator A5035649892 @default.
• W4313281041 creator A5040492090 @default.
• W4313281041 creator A5048474847 @default.
• W4313281041 creator A5049606209 @default.
• W4313281041 creator A5053260505 @default.
• W4313281041 creator A5054440348 @default.
• W4313281041 creator A5059751095 @default.
• W4313281041 creator A5062259629 @default.
• W4313281041 creator A5063321240 @default.
• W4313281041 creator A5065962812 @default.
• W4313281041 creator A5071498712 @default.
• W4313281041 creator A5075568384 @default.
• W4313281041 creator A5083319805 @default.
• W4313281041 creator A5085002917 @default.
• W4313281041 creator A5086664647 @default.
• W4313281041 date "2022-12-24" @default.
• W4313281041 modified "2023-10-18" @default.
• W4313281041 title "SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma" @default.
• W4313281041 cites W1589007430 @default.
• W4313281041 cites W1992521533 @default.
• W4313281041 cites W2121691257 @default.
• W4313281041 cites W2130019054 @default.
• W4313281041 cites W219963632 @default.
• W4313281041 cites W2223535266 @default.
• W4313281041 cites W2239158335 @default.
• W4313281041 cites W2508102725 @default.
• W4313281041 cites W2529089430 @default.
• W4313281041 cites W2566753678 @default.
• W4313281041 cites W2768591361 @default.
• W4313281041 cites W2777214868 @default.
• W4313281041 cites W2783764907 @default.
• W4313281041 cites W2801607709 @default.
• W4313281041 cites W2883258666 @default.
• W4313281041 cites W2883803263 @default.
• W4313281041 cites W2909910706 @default.
• W4313281041 cites W2911871569 @default.
• W4313281041 cites W2939322913 @default.
• W4313281041 cites W2943793201 @default.
• W4313281041 cites W2952065098 @default.
• W4313281041 cites W2972164676 @default.
• W4313281041 cites W2979937337 @default.
• W4313281041 cites W2985764787 @default.
• W4313281041 cites W2993982377 @default.
• W4313281041 cites W2995708286 @default.
• W4313281041 cites W3004013989 @default.
• W4313281041 cites W3005286250 @default.
• W4313281041 cites W3009077651 @default.
• W4313281041 cites W3012782412 @default.
• W4313281041 cites W3021534378 @default.
• W4313281041 cites W3035074270 @default.
• W4313281041 cites W3040788458 @default.
• W4313281041 cites W3077764649 @default.
• W4313281041 cites W3089875058 @default.
• W4313281041 cites W3101338849 @default.
• W4313281041 cites W3107334044 @default.
• W4313281041 cites W3111837629 @default.
• W4313281041 cites W3113175062 @default.
• W4313281041 cites W3121485073 @default.
• W4313281041 cites W3122102409 @default.
• W4313281041 cites W3156394540 @default.
• W4313281041 cites W3161919037 @default.
• W4313281041 cites W3169529258 @default.
• W4313281041 cites W3173874300 @default.
• W4313281041 cites W3201657639 @default.
• W4313281041 cites W4211050477 @default.
• W4313281041 cites W4229018851 @default.
• W4313281041 doi "https://doi.org/10.1038/s41419-022-05526-w" @default.
• W4313281041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36566214" @default.
• W4313281041 hasPublicationYear "2022" @default.
• W4313281041 type Work @default.
• W4313281041 citedByCount "10" @default.
• W4313281041 countsByYear W43132810412023 @default.
• W4313281041 crossrefType "journal-article" @default.
• W4313281041 hasAuthorship W4313281041A5012660792 @default.
• W4313281041 hasAuthorship W4313281041A5013285310 @default.
• W4313281041 hasAuthorship W4313281041A5018244700 @default.
• W4313281041 hasAuthorship W4313281041A5024152585 @default.
• W4313281041 hasAuthorship W4313281041A5024671320 @default.
• W4313281041 hasAuthorship W4313281041A5035649892 @default.
• W4313281041 hasAuthorship W4313281041A5040492090 @default.
• W4313281041 hasAuthorship W4313281041A5048474847 @default.
• W4313281041 hasAuthorship W4313281041A5049606209 @default.
• W4313281041 hasAuthorship W4313281041A5053260505 @default.
• W4313281041 hasAuthorship W4313281041A5054440348 @default.
• W4313281041 hasAuthorship W4313281041A5059751095 @default.
• W4313281041 hasAuthorship W4313281041A5062259629 @default.
• W4313281041 hasAuthorship W4313281041A5063321240 @default.
• W4313281041 hasAuthorship W4313281041A5065962812 @default.
• W4313281041 hasAuthorship W4313281041A5071498712 @default.
• W4313281041 hasAuthorship W4313281041A5075568384 @default.
• W4313281041 hasAuthorship W4313281041A5083319805 @default.
• W4313281041 hasAuthorship W4313281041A5085002917 @default.
• W4313281041 hasAuthorship W4313281041A5086664647 @default.

• next